Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BH.IMMUN&BIO vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BH.IMMUN&BIO   ACTAVIS
EQUITY SHARE DATA
    BH.IMMUN&BIO
Mar-23
ACTAVIS
Dec-18
BH.IMMUN&BIO/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs5216,126-   
Low Rs2110,818-   
Sales per share (Unadj.) Rs10.33,955.8-  
Earnings per share (Unadj.) Rs-3.9-1,274.2-  
Cash flow per share (Unadj.) Rs-3.8416.9-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs20.416,315.7-  
Shares outstanding (eoy) m43.18332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.53.4 102.7%   
Avg P/E ratio x-9.4-10.6 88.7%  
P/CF ratio (eoy) x-9.532.3 -29.4%  
Price / Book Value ratio x1.80.8 214.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,5614,480,758 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m1510-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m4461,315,689 0.0%  
Other income Rs m1125,160 0.0%   
Total revenues Rs m4571,340,849 0.0%   
Gross profit Rs m-16134,478 -0.5%  
Depreciation Rs m2562,428 0.0%   
Interest Rs m7175,923 0.1%   
Profit before tax Rs m-223-578,713 0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m-56-7,334 0.8%   
Profit after tax Rs m-166-423,784 0.0%  
Gross profit margin %-36.02.6 -1,374.6%  
Effective tax rate %25.31.3 1,994.7%   
Net profit margin %-37.3-32.2 115.8%  
BALANCE SHEET DATA
Current assets Rs m358539,627 0.1%   
Current liabilities Rs m940477,372 0.2%   
Net working cap to sales %-130.64.7 -2,759.1%  
Current ratio x0.41.1 33.7%  
Inventory Days Days8520 436.3%  
Debtors Days Days1,13566 1,712.2%  
Net fixed assets Rs m1,262148,929 0.8%   
Share capital Rs m4320-   
"Free" reserves Rs m4500-   
Net worth Rs m8825,426,601 0.0%   
Long term debt Rs m01,910,903 0.0%   
Total assets Rs m1,6208,483,012 0.0%  
Interest coverage x-2.2-6.6 32.5%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.30.2 177.6%   
Return on assets %-5.9-4.1 144.2%  
Return on equity %-18.9-7.8 241.5%  
Return on capital %-17.2-4.8 356.1%  
Exports to sales %00-   
Imports to sales %14.50-   
Net fx Rs m-650-   
CASH FLOW
From Operations Rs m109470,046 0.0%  
From Investments Rs m5258,229 0.0%  
From Financial Activity Rs m-147-806,740 0.0%  
Net Cashflow Rs m-34-78,073 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare BH.IMMUN&BIO With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare BH.IMMUN&BIO With: RAJNISH WELLNESS  LINK PHARMA  GUJ.INJ(KER)  NUTRAPLUS PR  SMRUTHI ORGANICS  



Today's Market

Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7% Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7%(Closing)

After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.